Search

Author/Creator Romero-Laorden, N.

1. Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients. (March 2019)

Authors:
Rogado, J.; Sánchez-Torres, J.M.; Romero-Laorden, N.; Ballesteros, A.I.; Pacheco-Barcia, V.; Ramos-Leví, A.; Arranz, R.; Lorenzo, A.; Gullón, P.; Donnay, O.; Adrados, M.; Costas, P.; Aspa, J.; Alfranca, A.; Mondéjar, R.; Colomer, R.
Journal:
European journal of cancer
Issue:
Volume 109(2019)
Page Start:
21
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. PD-0913 Local treatment to the primary tumor and PSA changes as prognostic factors in mCRPC. (August 2021)

Authors:
Lopez Campos, F.; Lorente, D.; Llacer-Pérez, C.; Henríquez, I.; Peleteiro, P.; Gómez-Iturriaga, A.; Ramírez-Backhaus, M.; Álvarez, S.; Alonso-Gordoa, T.; Molina-Cerrillo, J.; Vallejo, C.; Hervás, A.; Navarro-Castellón, J.; Gómez, J.; Morillo, V.; Lozano, R.; Romero-Laorden, N.; García, R.; Hernán...
Journal:
Radiotherapy and oncology
Issue:
Volume 161(2021)supplement
Page Start:
S755
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search